Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-16

Clinical Trial Update: Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy. [NA]

View source ↗

Summary

A clinical trial investigating personalized radiotherapy for biochemical recurrence of prostate cancer after prostatectomy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lund University Hospital | Conditions: Prostate Cancer | NA | Status: RECRUITING